Hologic hands corner office to former Stryker chief, takes on 2 Icahn board members

December 9, 2013 by Arezu Sarvestani

Hologic hands former Stryker CEO Steven MacMillan the keys to the corner office, agrees to take on 2 new board members to pacify an activist investor and enlists a new scientific advisor.

Hologic hands corner office to former Stryker chief, takes on 2 Icahn board members

Massachusetts medtech maker Hologic (NSDQ:HOLX) did some top-line rearranging, naming Steven MacMillan its new CEO and adding 2 members to its board of directors to appease an activist investor.

New CEO MacMillan has spent some 24 years in the medtech space, perhaps most notably as president & CEO for Stryker (NYSE:SYK). MacMillan resigned from Stryker's top spot in February 2012 amid a flurry of rumors and speculation about his personal life.

Sign up to get our free newsletters delivered right to your inbox.

"Since our 1st meeting with Steve in late October, it was clear that he is the right leader to take Hologic forward," Hologic board chairman David LaVance Jr. said in prepared remarks. "The board unanimously concluded that his track record of delivering strong financial results and creating shareholder value makes him the ideal chief executive officer for Hologic."

Comments